Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis

Chemotherapy

Volumn 49, Issue 4, 2003, Pages 159-162

  Barão, Sandra Cristina ^a   Giorgio, Selma ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

8 Bromoguanosine; Leishmania amazonensis; Leishmaniasis

Indexed keywords

8 BROMOGUANOSINE; ALANINE AMINOTRANSFERASE; ANTIMONY DERIVATIVE; GUANOSINE; MEGLUMINE ANTIMONATE; NUCLEOSIDE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; KIDNEY; LEISHMANIA; LIVER; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITOSIS; PATHOLOGY; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SKIN ULCER; SPLEEN; TOXICITY; UREA BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; FEMALE; GUANOSINE; HEMATOLOGIC TESTS; INJECTIONS, INTRAPERITONEAL; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; MICE; MICE, INBRED CBA; ORGANOMETALLIC COMPOUNDS; SKIN ULCER; TRYPANOCIDAL AGENTS; UREA;

EID: 0042242650     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071138     Document Type: Article

References (22)

1. Herwladt BL: Leishmaniasis. Lancet 1999;354:1191-1199.
2. Handman E: Leishmaniasis: Current status of vaccine development. Clin Microbiol Rev 2001;14:229-243.
3. Goodman MG: Cellular and biochemical studies of substituted guanine ribonucleoside immunostimulants. Immunopharmacology 1991;21:51-68.
4. Bonnet PA, Robins RK: Modulation of leukocyte genetic expression by novel purine nucleoside analogues. A new approach to antitumor and antiviral agents. J Med Chem 1993;36:635-653.
5. Ojo-Amaize EA, Rubalcava B, Avery TL, Cottam HB, Matsumoto SS, Jolley WB, Robins RK: Activation of respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at 7 and 8 positions: Possible involvement of a pertussis toxin-sensitive G-protein. Immunol Lett 1990;23:173-178.
6. Agarwala SS, Kirkwood JM, Bryant J: Phase I, randomized, double-blind trial of 7-allyl-8-oxo-guanosine (loxoribine) in advanced cancer. Cytokines Cell Mol Ther 2000;6:171-176.
7. Giorgio S, Barão SC, Augusto O, Kwee J: Leishmania amazonensis infection is reduced in macrophages treated with guanine ribonucleosides. Acta Trop 1998;70:119-112.
8. Giorgio S, Barão SC: Intracellular Leishmania amazonensis killing induced by the guanine nucleoside 8-bromoguanosine. Rev Inst Med Trop S Paulo 1998;40:237-240.
9. Barbieri CL, Giorgio S, Merjan JC, Figueiredo EN: Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody. Infect Immun 1993;61:2131-2137.
10. Gad SC, Chengelis CP: Animal Models in Toxicology. New York, Dekker, 1992.
11. Scheuer WV, Goodman MG, Parks DE, Weigle WO: Enhancement of the in vivo antibody response by an 8-derivatized guanine nucleoside. Cell Immunol 1985;91:294-300.
12. Takahashi Y, Kondo H, Yasuda T, Watanaba T, Kobayashi S, Yokohama S: Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs. Int J Pharm 2002;246:85-94.
13. Prak DJ, Pritchard PH: Solubilization of polycyclic aromatic hydrocarbon mixtures in micellar nonionic surfactant solutions. Water Res 2002;36:3463-3472.
14. Goodman MG, Weigle WO: Manifold amplification of in vivo immunity in normal and immunodeficient mice by ribonucleosides derivatized at C8 of guanine. Proc Natl Acad Sci USA 1983;80:3452-3455.
15. Chantot JF, Guschlbauer W: Physicochemical properties of nucleosides 3. Gel formation by 8-bromoguanosine. FEBS Lett 1969;4:173-176.
16. Walters KA, Dugard PH, Florence AT: Non-ionic surfactants and gastric mucosal transport of paraquat. J Pharm Pharmacol 1981;33:207-213.
17. Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh, Ghafourian T, Barzegar-Jalali: The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250:359-369.
18. Goodman MG: Role of salvage and phosphorylation in the immunostimulatory activity of C8-substituted guanine ribonucleosides. J Immunol 1988;141:2394-2399.
19. Goodman MG, Weigle WO: Intracellular lymphocyte activation and carrier-mediated transport of C8-substituted guanine ribonucleosides. Proc Natl Acad Sci USA 1984;81:862-866.
20. Goodman MG: A new approach to vaccine adjuvants; in Powell MF, Newman MJ (eds): Vaccine Design: The Subunit and Adjuvant Approach. New York, Plenun Press, 1995, pp 581-609.
21. Koo GC, Jewell ME, Manyac CL, Sigal NH, Wicker LS: Activation of murine natural killer cells and macrophages by 8-bromoguanosine. J Immunol 1988;140:3249-3252.
22. Goodman MG: Induction of interleukin 1 activity from macrophages by direct interaction with C8-substituted guanine ribonucleosides. Int J Immunopharmacol 1988;10:579-586.